High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal Cancer

Japanese Journal of Cancer Research

Volumn 86, Issue 9, 1995, Pages 847-853

  Kan, Masaharu ^a   Aki, Masashi ^b   Akiyama, Kinya ^a   Naruo, Seiichi ^a   Kanayama, Hiro‐omi ^a   Kagawa, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Fujisaki Hospital   (Japan)

Author keywords

CD44; Exon v10; Renal cancer; RT PCR

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL LINE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, RENAL CELL; COMPARATIVE STUDY; EXONS; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0029160732     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1995.tb03095.x     Document Type: Article

References (24)

1. Correlation between circulating cancer cells and incidence of metastasis
2. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man
3. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95‐kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells
4. CD44 contributes to T cell activation
5. Dual role of the CD44 molecule in T cell adhesion and activation
6. Expression of CD44 confers a new adhesive phenotype on transfected cell
7. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells
8. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracelllar domain
9. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
10. Splicing choice from ten variant exons establishes CD44 variability
11. Significance of CD44 gene products for cancer diagnosis and disease evaluation
12. Differential expression of the CD44 molecules in human brain tumors
13. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
14. Non‐invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells
15. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymphvascular space involvement of cancer cells
16. Participation in normal immune responses of a metastasis‐inducing splice variant of CD44
17. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior
18. Prevention of tumor metastasis formation by anti‐variant CD44
19. Isolation and characterization of human melanoma cell variants expressing high and low level of CD44
20. Differential expression of CD44 splice variants in intestinal‐ and diffuse type human gastric carcinomas and normal gastric mucosa
21. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases
22. A human homologue of rat metastasis‐associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
23. Expression and modulation of CD44 variant isoforms in humans
24. Serum levels and gene expressions of interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6) and tumor necrosis factor‐α (IL‐α) in human renal cell carcinomas